P

Inventor

WALTER STEFFEN

DE122 patents
⚠️ This page may combine multiple inventors who share the name “WALTER STEFFEN”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

IMMATICS BIOTECHNOLOGIES GMBH

42 patents
US10071148B2Sep 11, 2018

Immunotherapy against several tumors, such as lung cancer, including NSCLC

IMMATICS BIOTECHNOLOGIES GMBH198 citations99
US9993523B2Jun 12, 2018

Immunotherapy against several tumors including gastrointestinal and gastric cancer

IMMATICS BIOTECHNOLOGIES GMBH52 citations99
US9950048B2Apr 24, 2018

Immunogenic epitopes for immunotherapy

IMMATICS BIOTECHNOLOGIES GMBH106 citations99
US9943579B2Apr 17, 2018

Immunotherapy against several tumors, such as lung cancer, including NSCLC

IMMATICS BIOTECHNOLOGIES GMBH131 citations99
US9895415B2Feb 20, 2018

Immunotherapy against several tumors including gastrointestinal and gastric cancer

IMMATICS BIOTECHNOLOGIES GMBH55 citations99
US9717774B2Aug 1, 2017

Immunotherapy against several tumors including gastrointestinal and gastric cancer

IMMATICS BIOTECHNOLOGIES GMBH63 citations99
US9511128B2Dec 6, 2016

Immunogenic epitopes for immunotherapy

IMMATICS BIOTECHNOLOGIES GMBH113 citations99
US11273200B2Mar 15, 2022

Immunotherapy against several tumors including gastrointestinal and gastric cancer

IMMATICS BIOTECHNOLOGIES GMBH15 citations98
US11077171B2Aug 3, 2021

Immunotherapy against several tumors including gastrointestinal and gastric cancer

IMMATICS BIOTECHNOLOGIES GMBH18 citations98
US10933118B2Mar 2, 2021

Immunotherapy against several tumors including gastrointestinal and gastric cancer

IMMATICS BIOTECHNOLOGIES GMBH18 citations98
US10898546B2Jan 26, 2021

Immunotherapy against several tumors including gastrointestinal and gastric cancer

IMMATICS BIOTECHNOLOGIES GMBH15 citations98
US10420800B2Sep 24, 2019

Immunotherapy against neuronal and brain tumors

IMMATICS BIOTECHNOLOGIES GMBH53 citations98
US10420816B1Sep 24, 2019

Immunotherapy against several tumors including gastrointestinal and gastric cancer

IMMATICS BIOTECHNOLOGIES GMBH21 citations98
US10357540B2Jul 23, 2019

Immunotherapy against several tumors including gastrointestinal and gastric cancer

IMMATICS BIOTECHNOLOGIES GMBH18 citations98
US10227381B2Mar 12, 2019

Immunotherapy against several tumors including neuronal and brain tumors

IMMATICS BIOTECHNOLOGIES GMBH37 citations98
US10100085B2Oct 16, 2018

Immunotherapy against several tumors including neuronal and brain tumors

IMMATICS BIOTECHNOLOGIES GMBH35 citations98
US10047124B2Aug 14, 2018

Immunotherapy against several tumors including neuronal and brain tumors

IMMATICS BIOTECHNOLOGIES GMBH41 citations98
US10046037B2Aug 14, 2018

Immunotherapy against several tumors including neuronal and brain tumors

IMMATICS BIOTECHNOLOGIES GMBH41 citations98
US10047123B2Aug 14, 2018

Immunotherapy against several tumors including neuronal and brain tumors

IMMATICS BIOTECHNOLOGIES GMBH41 citations98
US9993540B2Jun 12, 2018

Immunotherapy against several tumors including neuronal and brain tumors

IMMATICS BIOTECHNOLOGIES GMBH40 citations98
US11890334B2Feb 6, 2024

Personalized immunotherapy against several neuronal and brain tumors

IMMATICS BIOTECHNOLOGIES GMBH8 citations94
US11759507B2Sep 19, 2023

Personalized immunotherapy against several neuronal and brain tumors

IMMATICS BIOTECHNOLOGIES GMBH9 citations94
US11607446B2Mar 21, 2023

Personalized immunotherapy against several neuronal and brain tumors

IMMATICS BIOTECHNOLOGIES GMBH14 citations94
US11529401B2Dec 20, 2022

Personalized immunotherapy against several neuronal and brain tumors

IMMATICS BIOTECHNOLOGIES GMBH14 citations94
US11529400B1Dec 20, 2022

Personalized immunotherapy against several neuronal and brain tumors

IMMATICS BIOTECHNOLOGIES GMBH14 citations94
US11524059B2Dec 13, 2022

Personalized immunotherapy against several neuronal and brain tumors

IMMATICS BIOTECHNOLOGIES GMBH14 citations94
US11298404B2Apr 12, 2022

Immunotherapy against several tumors including gastrointestinal and gastric cancer

IMMATICS BIOTECHNOLOGIES GMBH14 citations94
US11208434B2Dec 28, 2021

Immunotherapy against several tumors including neuronal and brain tumors

IMMATICS BIOTECHNOLOGIES GMBH14 citations94
US11136352B2Oct 5, 2021

Immunotherapy against several tumors including neuronal and brain tumors

IMMATICS BIOTECHNOLOGIES GMBH11 citations94
US10946064B2Mar 16, 2021

Personalized immunotherapy against several neuronal and brain tumors

IMMATICS BIOTECHNOLOGIES GMBH15 citations94
US10941181B2Mar 9, 2021

Immunotherapy against several tumors including neuronal and brain tumors

IMMATICS BIOTECHNOLOGIES GMBH14 citations94
US10919931B2Feb 16, 2021

Immunotherapy against several tumors including neuronal and brain tumors

IMMATICS BIOTECHNOLOGIES GMBH14 citations94
US10905741B2Feb 2, 2021

Immunotherapy against several tumors including gastrointestinal and gastric cancer

IMMATICS BIOTECHNOLOGIES GMBH10 citations94
US10906936B2Feb 2, 2021

Immunotherapy against several tumors including neuronal and brain tumors

IMMATICS BIOTECHNOLOGIES GMBH15 citations94
US10550182B2Feb 4, 2020

T cell receptors and immune therapy using the same

IMMATICS BIOTECHNOLOGIES GMBH15 citations94
US10526407B2Jan 7, 2020

T cell receptors and immune therapy using the same

IMMATICS BIOTECHNOLOGIES GMBH17 citations94
US10478471B2Nov 19, 2019

Immunotherapy against several tumors including gastrointestinal and gastric cancer

IMMATICS BIOTECHNOLOGIES GMBH13 citations93
US10479818B2Nov 19, 2019

Immunotherapy against several tumors, such as lung cancer, including NSCLC

IMMATICS BIOTECHNOLOGIES GMBH7 citations93
US10323065B1Jun 18, 2019

Immunotherapy against several tumors, such as lung cancer, including NSCLC

IMMATICS BIOTECHNOLOGIES GMBH10 citations93
US10316063B1Jun 11, 2019

Immunotherapy against several tumors, such as lung cancer, including NSCLC

IMMATICS BIOTECHNOLOGIES GMBH11 citations93
US10160786B1Dec 25, 2018

Immunotherapy against several tumors, such as lung cancer, including NSCLC

IMMATICS BIOTECHNOLOGIES GMBH12 citations93
US7994276B2Aug 9, 2011

Composition of tumour-associated peptides and related anti-cancer vaccine

IMMATICS BIOTECHNOLOGIES GMBH30 citations93

SINGH HARPREET

4 patents

WEINSCHENK TONI

3 patents

FRITSCHE JENS

1 patent

Showing the top 50 of 122 patents by PatentIndex Score.